R&D Systems™ Recombinant Human BTLA Fc Chimera (aa 25-150) Protein

Catalog No.
83-85B-T050	50ug; Carrier Free

Catalog No. 83-85B-T050 Supplier R&D Systems™ Supplier No. 8385BT050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its binding ability in a functional ELISA. When Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (Catalog # 2516-HV ) is immobilized at 0.5 μg/mL (100 μL/well), the concentration of Recombinant Human BTLA Fc Chimera that produces 50% of the optimal binding response is approximately 0.25-1.25 μg/mL.

Specifications

• Accession Number: AAP44003
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 151888
• Molecular Weight (g/mol): M.W. (Observed): 53-65 kDa, reducing conditions; M.W. (theoretical): 41 kDa
• Name: BTLA Fc Chimera
• Preparation Method: Reconstitute at 500μg/mL in PBS.
• Quality Control Testing: SDS-PAGE: 53-65kDa, reducing conditions
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human BTLA protein Human BTLA Ile25-Ser150 (N-terminus) Accession # AAP44003 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Termination: Ile25
• Without Additives: Carrier Protein
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: BTLA
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >85%, by SDS-PAGE with silver staining.
• Protein: BTLA/CD272